Bd Phoenix Automated Microbiology System - Erythromycin-0.0625-8 Ug/Ml, and Quinupristin/Dalfopristin-0.25-4 Ug/Ml
510(k) K060218
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK060218 | Date17 Mar 2006 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LON
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.1645
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The BD Phoenix Automated Microbiology System is an automated antimicrobial susceptibility testing device designed for the rapid identification and in vitro testing of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria from human clinical isolates. It employs standardized antimicrobial agents, including erythromycin (0.0625–8 µg/ml) and quinupristin/dalfopristin (0.25–4 µg/ml), to determine bacterial resistance patterns in a streamlined, automated workflow.
This system is intended for use in clinical microbiology laboratories and is supplied as a reusable instrument with disposable consumables. It operates under non-sterile conditions for the instrument itself, though consumables may require sterile handling as per manufacturer guidelines. The device is classified under FDA 510(k) clearance (K060218) and adheres to regulatory standards for antimicrobial susceptibility testing, including compliance with 21 CFR Part 866.1645. No MRI safety information or specific storage conditions are noted in the regulatory data.
Other devices from Becton, Dickinson & Co.
Questions
AI-generated answers, 1 Oct 2026
What is the BD Phoenix Automated Microbiology System with erythromycin and quinupristin/dalfopristin used for?
This system is designed for rapid in vitro antimicrobial susceptibility testing of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria from human clinical isolates. It helps determine bacterial resistance patterns to specific antimicrobial agents, including erythromycin (0.0625–8 µg/ml) and quinupristin/dalfopristin (0.25–4 µg/ml), streamlining workflows in clinical microbiology labs.
How is the BD Phoenix Automated Microbiology System supplied, and are the consumables sterile?
The system is supplied as a reusable instrument with disposable consumables. While the instrument itself is non-sterile, the consumables may require sterile handling as per manufacturer guidelines. This ensures proper use in clinical settings where sterility is critical for patient safety.
Is the BD Phoenix Automated Microbiology System single-use or reusable?
The BD Phoenix Automated Microbiology System itself is a reusable instrument. However, it relies on disposable consumables for each testing cycle, which must be replaced after use. This design balances durability with hygiene and workflow efficiency.
What regulatory pathway does the BD Phoenix Automated Microbiology System follow?
The device follows the FDA 510(k) clearance pathway, specifically under the classification of substantially equivalent (SESE) to a predicate device. It adheres to regulatory standards outlined in 21 CFR Part 866.1645, ensuring compliance with antimicrobial susceptibility testing requirements in clinical microbiology.
Are there any special storage conditions or MRI safety considerations for this device?
The regulatory data does not specify any special storage conditions or MRI safety information for the BD Phoenix Automated Microbiology System. Standard laboratory storage practices should be followed to maintain optimal performance and longevity of the reusable instrument.